v3.26.3
DIVISION INFORMATION (SEGMENT REPORTING) (Tables)
9 Months Ended
Sep. 30, 2026
DIVISION INFORMATION (SEGMENT REPORTING)  
Schedule of reconciliation of segment operating profit or loss to consolidated net loss

​

​

​

​

​

​

​

​

​

​

​

​

Three Months Ended September 30, 

​

Nine Months Ended September 30, 

​

  ​ ​ ​

2026

  ​ ​ ​

2025

 

2026

  ​ ​ ​

2025

Operating loss

 

(6,855)

 

(5,818)

​

(22,233)

 

(18,674)

Financial (expense) income, net

 

2,032

 

(56)

​

(5,989)

 

(103)

Foreign currency exchange (losses) gains, net

 

573

 

55

​

625

 

(640)

Income tax (expense) benefit

 

(212)

 

(121)

​

(435)

 

(373)

Consolidated net loss

 

(4,462)

 

(5,940)

​

(28,032)

 

(19,790)

Schedule of segment reporting information by segment

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Three Months Ended

  ​ ​ ​

HIFU

  ​ ​ ​

Reconciling

  ​ ​ ​

Total

September 30, 2026

​

Division

​

Items

​

continuing

Sales of goods

 

6,489

​

—

 

6,489

Sales of RPPs & leases

 

2,367

​

—

 

2,367

Sales of spare parts and services

 

972

​

—

 

972

Total sales

 

9,828

​

—

 

9,828

Total cost of sales

 

(4,776)

​

—

 

(4,776)

Gross profit

 

5,053

​

—

 

5,053

R&D expenses

 

(2,458)

​

—

 

(2,458)

Selling and marketing expenses

 

(5,914)

​

—

 

(5,914)

General and administrative expenses

 

(2,823)

 

(1,634)

 

(4,458)

Total expenses

 

(11,195)

 

(1,634)

 

(12,829)

Operating income (loss) from operations

 

(6,142)

 

(1,634)

 

(7,777)

Total Assets

 

44,686

​

48,703

 

93,389

Net cash generated by (used in) investing activities

 

(1,326)

​

—

 

(1,326)

Non-current assets

 

15,933

​

—

 

15,933

Goodwill

 

732

​

—

 

732

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Three Months Ended

  ​ ​ ​

HIFU

  ​ ​ ​

Reconciling

  ​ ​ ​

Total

September 30, 2025

​

Division

​

Items

​

continuing

Sales of goods

 

4,895

 

—

 

4,895

Sales of RPPs & leases

 

2,216

 

—

 

2,216

Sales of spare parts and services

 

717

 

—

 

717

Total sales

 

7,828

 

—

 

7,828

Total cost of sales

 

(4,181)

 

—

 

(4,181)

Gross profit

 

3,647

 

—

 

3,647

R&D expenses

 

(2,303)

 

—

 

(2,303)

Selling and marketing expenses

 

(4,181)

 

—

 

(4,181)

General and administrative expenses

 

(2,575)

 

(1,258)

 

(3,833)

Total expenses

 

(9,059)

 

(1,258)

 

(10,316)

Operating income (loss) from operations

 

(5,412)

 

(1,258)

 

(6,669)

Total Assets

 

48,538

​

5,331

 

53,870

Net cash generated by (used in) investing activities

 

(884)

​

—

 

(884)

Non-current assets

 

14,795

​

—

 

14,795

Goodwill

 

757

​

—

 

757

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Nine months ended

  ​ ​ ​

HIFU

  ​ ​ ​

Reconciling

  ​ ​ ​

Total

September 30, 2026

​

Division

​

Items

​

continuing

Sales of goods

 

24,272

​

—

 

24,272

Sales of RPPs & leases

 

7,617

​

—

 

7,617

Sales of spare parts and services

 

2,736

​

—

 

2,736

Total sales

 

34,624

​

—

 

34,624

Total cost of sales

 

(16,271)

​

—

 

(16,271)

Gross profit

 

18,353

​

—

 

18,353

R&D expenses

 

(7,242)

​

—

 

(7,242)

Selling and marketing expenses

 

(19,747)

​

—

 

(19,747)

General and administrative expenses

 

(9,298)

 

(5,899)

 

(15,198)

Total expenses

 

(36,287)

 

(5,899)

 

(42,186)

Operating income (loss) from operations

 

(17,935)

 

(5,899)

 

(23,834)

Total Assets

 

44,686

​

48,703

 

93,389

Net cash generated by (used in) investing activities

 

(3,006)

​

—

 

(3,006)

Non-current assets

 

15,933

​

—

 

15,933

Goodwill

 

732

​

—

 

732

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Nine months ended

  ​ ​ ​

HIFU

  ​ ​ ​

Reconciling

  ​ ​ ​

Total

September 30, 2025

​

Division

​

Items

​

continuing

Sales of goods

 

15,081

 

—

 

15,081

Sales of RPPs & leases

 

6,315

 

—

 

6,315

Sales of spare parts and services

 

2,441

 

—

 

2,441

Total sales

 

23,838

 

—

 

23,838

Total COS

 

(12,170)

 

—

 

(12,170)

Gross profit

 

11,667

 

—

 

11,667

R&D expenses

 

(6,951)

 

—

 

(6,951)

Selling and marketing expenses

 

(13,874)

 

—

 

(13,874)

G&A expenses

 

(7,359)

 

(3,519)

 

(10,879)

Total expenses

 

(28,185)

 

(3,519)

 

(31,704)

Operating income (loss) from operations

 

(16,517)

 

(3,519)

 

(20,037)

Total Assets

 

48,538

​

5,331

 

53,870

Net cash generated by (used in) investing activities

 

(3,626)

​

—

 

(3,626)

Non-current assets

 

14,795

​

—

 

14,795

Goodwill

 

757

​

—

 

757

​